Effects of nebulized NG-nitro-L-arginine
β
Federico P. GΓ³mez; Joan A. BarberΓ ; Josep Roca; Felip Burgos; ConcepciΓ³n Gistau;
π
Article
π
2006
π
John Wiley and Sons
π
English
β 442 KB
Enhanced pulmonary production of nitric oxide (NO) has been implicated in the pathogenesis of hepatopulmonary syndrome (HPS). NO inhibition with N(G)-nitro-L-arginine methyl ester (L-NAME) in both animals and humans with HPS has improved arterial hypoxemia. We assessed the role of enhanced NO produc